gas sensing News
-
Showcase
Atmo Biosciences awarded Victorian Government Technology Adoption and Innovation Program grant to support software development
Atmo Biosciences has been awarded a Victorian Government Technology Adoption and Innovation Program (TAIP) grant to support the software development for the Atmo Gas Capsule. The TAIP supports Victorian small to medium size enterprises (SMEs) to adopt or develop innovative, new and commercial technology. Atmo was awarded the full $50,000 grant amount, which will go towards hiring a Principal ...
-
Showcase
Atmo Biosciences awarded Australian Government grant to automate and scale-up manufacturing of ingestible gas-sensing capsule
Atmo Biosciences has been awarded an Australian Government Manufacturing Modernisation Fund (MMF) grant to support manufacturing automation and scale-up for the Atmo Gas-Sensing Capsule. The Round 2 MMF grants, part of the Government’s Modern Manufacturing Strategy, are for small-medium sized businesses to transform manufacturing and to support job growth and develop a more skilled ...
-
Study results presented at AGW show Atmo Gas Capsule can be used to assess regional gastrointestinal transit in healthy adults
A Monash University comparative study has found Atmo Biosciences’ novel ingestible gas-sensing capsule to be similar to a validated wireless motility capsule (WMC) when assessing regional gastrointestinal transit time in healthy adults. Findings from the study, led by Professor Peter Gibson, are being presented in a poster at Australian Gastroenterology Week (AGW), being held virtually ...
-
Atmo featured on Medical Director’s Healthtech Showcase
Atmo Biosciences CEO Mal Hebblewhite was invited to present at Medical Director’s Healthtech Showcase. In the video below, Mal gives an overview of Atmo Biosciences then talks to showcase host Dominique Powis about Atmo’s journey so far, and how its ingestible gas-sensing capsule can improve diagnosis and treatment for common gastrointestinal disorders. ...
-
Atmo Biosciences’ ingestible gas-sensing capsule to be used in Swedish IBS trial led by Professor Magnus Simrén
Atmo Biosciences’ world-first ingestible gas-sensing capsule is being used in a clinical trial led by renowned gastroenterologist Professor Magnus Simrén currently underway at Sweden’s University of Gothenburg. The trial named “The effects of carbohydrates in irritable bowel syndrome” is using the Atmo Gas Capsule digital biomarker platform to profile gases within ...
-
Atmo Biosciences signs deal with RMIT University to commercialize ingestible gas-sensing capsule for gut health
Atmo Biosciences has signed a licensing deal with RMIT University securing the exclusive worldwide rights to commercialize a ground-breaking ingestible gas-sensing capsule. The Atmo Gas Capsule is set to revolutionize how doctors diagnose and treat common gastrointestinal (GI) disorders by offering a non-invasive, low-cost, and more accurate alternative to current technologies. Patients with ...
-
Human trials underway for first generation Atmo Gas Capsule
Two human trials of Atmo Biosciences’ ingestible gas-sensing capsule have begun. The first trial is being conducted at Monash University and the Alfred Hospital in Melbourne, Australia, in collaboration with the research team led by Professor Peter Gibson and Professor Jane Muir. The trial will investigate motility and transit time through the gastrointestinal tract for the Atmo Gas ...
-
Airwave Electronics/Environmental Developing Device to Remotely Screen for COVID-19
Canada-based Airwave Electronics/Environmental, a long-time innovator in chemical gas sensing technologies, is developing a device to detect the COVID-19 virus immediately and at safe social distancing. Technology that has long been used throughout the world to detect gas leaks and monitor pollution levels is now being developed to screen for public health. The device leverages the same concept ...
-
Atmo Biosciences secures $9.6 million in oversubscribed capital raise
Atmo Biosciences has closed a successful, oversubscribed A$9.6m capital raise. The raise was led by two new, cornerstone investors – Sydney-based investment firm Alium Capital Management and Japanese multinational company Otsuka Pharmaceutical. The funding will enable Atmo to accelerate product development of its gas-sensing capsule, which detects clinically important gaseous biomarkers ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you